Does ETELCALCETIDE Cause Interstitial lung disease? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Interstitial lung disease have been filed in association with ETELCALCETIDE (PARSABIV). This represents 0.3% of all adverse event reports for ETELCALCETIDE.
9
Reports of Interstitial lung disease with ETELCALCETIDE
0.3%
of all ETELCALCETIDE reports
3
Deaths
7
Hospitalizations
How Dangerous Is Interstitial lung disease From ETELCALCETIDE?
Of the 9 reports, 3 (33.3%) resulted in death, 7 (77.8%) required hospitalization, and 1 (11.1%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ETELCALCETIDE. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does ETELCALCETIDE Cause?
Underdose (246)
Shunt stenosis (202)
Nausea (182)
Product storage error (148)
Blood parathyroid hormone increased (142)
Hypocalcaemia (140)
Shunt occlusion (126)
Blood calcium decreased (119)
Diarrhoea (107)
Vomiting (102)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which ETELCALCETIDE Alternatives Have Lower Interstitial lung disease Risk?
ETELCALCETIDE vs ETEPLIRSEN
ETELCALCETIDE vs ETESEVIMAB
ETELCALCETIDE vs ETHACRYNIC ACID
ETELCALCETIDE vs ETHAMBUTOL
ETELCALCETIDE vs ETHAMBUTOL\ISONIAZID\PYRAZINAMIDE\RIFAMYCIN